Aralez Bio uses engineered enzymes to make valuable products in a sustainable way.
Aralez Bio has raised $12.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
Aralez Bio's investors include Paladin Capital Group, Good Growth Capital, Astia, Freeflow Ventures, Impact Science Ventures.
Aralez Bio is headquartered in Emeryville, United States.
Aralez Bio uses engineered enzymes to make valuable products in a sustainable way.
Aralez Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aralez Bio — Funding & Investors." VCBacked, October 29, 2024, https://www.vcbacked.co/company/aralez-bio. Accessed October 29, 2026.
VCBacked. (2024). Aralez Bio — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/aralez-bio
{{cite web |title=Aralez Bio — Funding & Investors |url=https://www.vcbacked.co/company/aralez-bio |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated